Literature DB >> 29608024

Minimally Invasive Ultrasound-Guided Carpal Tunnel Release: Preliminary Clinical Results.

P Troy Henning1, Lynda Yang2, Tariq Awan3, Daniel Lueders4, Adam M Pourcho1.   

Abstract

Ultrasound-guided carpal tunnel release was performed on 14 patients (18 wrists) using dynamic expansion of the transverse safe zone. Our patient population included able-bodied patients and those with impairments. The first 8 cases (12 wrists) underwent the procedure in an operating room, the remainder in an outpatient setting. No complications occurred, and all patients were able to immediately resume use of their hands without therapy. Improvements in the Quick Form of the Disabilities of the Arm, Shoulder, and Hand Index and Boston Carpal Tunnel Questionnaire at 3 months were comparable to results reported with mini-open and endoscopic release. Our results show that ultrasound-guided carpal tunnel release can be safely and effectively performed in an outpatient setting.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  carpal tunnel release; median nerve; musculoskeletal (interventional); ultrasound

Mesh:

Year:  2018        PMID: 29608024     DOI: 10.1002/jum.14618

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  3 in total

1.  Ultrasound-Guided Cutting Wire Release of the Proximal Adductor Longus Tendon: A Feasibility Study.

Authors:  Brennan J Boettcher; John H Hollman; Michael J Stuart; Jonathan T Finnoff
Journal:  Orthop J Sports Med       Date:  2019-08-26

2.  Office-Based Carpal Tunnel Release Using Ultrasound Guidance in a Community Setting: Long-Term Results.

Authors:  Russell A Bergum; Mark R Ciota
Journal:  Cureus       Date:  2022-07-23

3.  Ultrasound-Guided Minimal Invasive Carpal Tunnel Release: An Optimized Algorithm.

Authors:  Alexander Loizides; Sarah Honold; Elisabeth Skalla-Oberherber; Leonhard Gruber; Wolfgang Löscher; Bernhard Moriggl; Marko Konschake; Hannes Gruber
Journal:  Cardiovasc Intervent Radiol       Date:  2021-02-24       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.